News
News Update
Business Wire
Press Releases
Economy
Business Life
Opinion
Legal Center
Classifieds
Executive Calendar
Networking Calendar
Subscribe
Archives
Contact Us
Links
Media Kit
Home



Press Releases
Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Mers CoV Virus Gene Replikins Found Conserved and Shared in Current Strains Back to 2012
Dengue Virus Gene Replikins Found Conserved and Shared in Current Dengue Strains Back to 1944
Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder
FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database English
Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes
Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60
Study Results Using OncoE6™ Oral and Cervical Tests
Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody for immunotherapy research English
Alzheimer's Prevention Registry Reaches Recruitment Milestone of 40,000 Individuals
Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. English
Data on XARELTO® at ESC Congress 2014 Hot Line Session Premieres First Prospective Study of a Factor Xa Inhibitor in Elective Cardioversion
Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion™ BLA
U.S. Army Funds Phase II Clinical Trial at UCLA for the Treatment of PTSD with the NeuroSigma eTNS System
Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial
BioLife Solutions CryoStor® AND HypoThermosol® Now Embedded In 130 Regenerative Medicine Clinical Trials English
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
SQI Diagnostics Contracted to Automate Pathogen Detection Assays
BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite
OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer
Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients
A new trial tests a combination of Vitamin C and "core" low dose, chemotherapy to reproduce promising safety and efficacy findings
DNA Test for Congenital Cataracts Leads to Faster, More Accurate Diagnoses of Rare Diseases Linked to Childhood Blindness
Visiting Scientist and Engineer Expand Discoveries at Allen Institute for Brain Science
Madonna Rehabilitation Hospital: NIH And NSF Award Research Grant To Dr. Fager For Wireless Sensor Research
Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite
Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies
Second Sight Argus® II Retinal Prosthesis System Wins Financial Support Agreement in France
Star Lineup Set for MDA Show of Strength Telethon This Labor Day Weekend
Hallmark Channel Features Dr. David Amron and Patient to Discuss Lipedema
Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc.
Debbie's Dream Foundation's New York Chapter President to Climb Mount Kilimanjaro
Trovagene Provides Update on Its Urine-Based HPV Test
Analysis Of Available Data From Optimeyes Study (Blinded And Open Label) Of Optina™ For The Treatment Of Diabetic Macular Edema (DME) Indicates Potential For Significant Clinical Benefit
Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody
KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema
Journal of the American Medical Association Publishes New Study Offering Further Validation for Newborn Screening for SCID, a Life-Threatening Primary Immune Disorder
Research study at Banner MD Anderson Cancer Center tests new drug to fight BRCA-associated breast cancer
Scientific Data Supports Superiority of Pivotal's Unique Omega-3 Formulation
ViaCyte, Inc. Announces FDA Acceptance of IND to Commence Clinical Trial of VC-01™ Candidate Cell Replacement Therapy for Type 1 Diabetes
Oramed Granted Patent in Spain for Oral Administration of Insulin
DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer
Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting
Actavis Announces Positive Topline Results From The Phase III Program Of Ceftazidime-Avibactam In Patients With Complicated Intra-Abdominal Infections(cIAI)
iCo Therapeutics Announces Positive Oral Amphotericin B Study Results
Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis
New Research by Wellesley Neuroscientist Shows Blood Cells Generate Neurons in Crayfish; Could Have Implications for Treatment of Neurodegenerative Disorders
Lung Cancer Alliance Applauds Launch of Innovative Trial at National Cancer Institute
UMDF Launches Mitochondrial Disease Community Registry
PCORI Offers Up to $90 Million in Funding in Third Call for Large Pragmatic Studies Proposals

< Prev Next >
PR Newswire - United Business Media


Search Classifieds:


Copyright © , Las Vegas Business Press